Research Article
H-Ferritin Affects Cisplatin-Induced Cytotoxicity in Ovarian Cancer Cells through the Modulation of ROS
Table 1
Clinical, pathological, and surgical characteristics of patients with High-Grade Serous Ovarian Cancer (HGSC).
| | HGSC () |
| Age (years) | | FIGO stage (, %) | | Stage II | 7 (25.0) | Stage III | 15 (53.6) | Stage IV | 6 (21.4) | Primary debulking surgery (, %) | 17 (100) | Chemotherapy (, %) | | Platinum+Taxol+Beva | 28 (100) | Response to chemotherapy | | Resistant | 13 (46.4) | Sensitive | 15 (53.6) | Major comorbidities (, %) | 5 (17.8) | Follow-up (months) | |
|
|